NCT01696565View on ClinicalTrials.gov

PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Neoplasm MetastasisNeoplasm Recurrence
Interventions
DRUG

PG2

Injectable

Trial Locations (1)

114

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY